doi: 10.3389/fnut.2024.1346452 Received 29 November 2023 Accepted 08 March 2024 Published 19 March 2024 Volume 11 - 2024 Edited by Akira Sugawara, Tohoku University, Japan Reviewed by Fan Zhang, The First Affiliated Hospital of China Medical University, China Sonya Vasto, University of Palermo, Italy Updates Copyright 2024 Zhang, Shang, Liu and Zhai
It is the first FDA approved medication to treat moderate to severe binge eating disorder
For more information: Kristy A
Osteoblast stimulation
Many patients find relief through non-pharmacologic strategies: reducing the pace of weight loss via slower dose escalation, incorporating strength training to stabilize joints, maintaining adequate protein intake to preserve muscle mass, and using anti-inflammatory approaches like omega-3 supplementation or physical therapy
PlexusDx providers monitor both your symptom comfort and your clinical progress to ensure your therapy is effective and tolerable